Skip to content
Clinical Trials for Alzheimer's Disease

Oklahoma

Alzheimer's disease clinical trials in Oklahoma

4 Alzheimer's disease studies are recruiting participants at sites in 2 cities across Oklahoma as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Oklahoma city with a recruiting study

Oklahoma City (3), Tulsa (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Oklahoma

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Tulsa
    Registry record
    NCT07011732 · updated
  2. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Oklahoma City
    Registry record
    NCT06585787 · updated
  3. Using Light Therapy for Mild Cognitive Impairment

    • No phase
    • Ages 55 to 95
    • All sexes
    Sponsor
    University of Oklahoma
    Recruiting in
    Oklahoma City
    Registry record
    NCT07651787 · updated
  4. Open-label Extension Study in Participants With Early Alzheimer's Disease

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    GlaxoSmithKline
    Recruiting in
    Oklahoma City
    Registry record
    NCT07105709 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Oklahoma on ClinicalTrials.gov.

Ask about studies in Oklahoma

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call